AAAAAA

   
Results: << | 101-125 | 126-150 | 151-158
Results: 101-125/158

Authors: HASHIMOTO T GAO XM TAMMINGA CA
Citation: T. Hashimoto et al., CHANGES IN BRAIN GAD MESSENGER-RNA IN NEUROLEPTIC-TREATED RATS, Schizophrenia research, 15(1-2), 1995, pp. 207-207

Authors: LAHTI AC KOFFEL B LAPORTE D TAMMINGA CA
Citation: Ac. Lahti et al., SUBANESTHETIC DOSES OF KETAMINE STIMULATE PSYCHOSIS IN SCHIZOPHRENIA, Neuropsychopharmacology, 13(1), 1995, pp. 9-19

Authors: ROBERTS RC GAITHER LA GAO XM KASHYAP SM TAMMINGA CA
Citation: Rc. Roberts et al., ULTRASTRUCTURAL CORRELATES OF HALOPERIDOL-INDUCED ORAL DYSKINESIAS INRAT STRIATUM, Synapse, 20(3), 1995, pp. 234-243

Authors: LAHTI RA LAHTI AC TAMMINGA CA
Citation: Ra. Lahti et al., D-2-FAMILY RECEPTORS IN SCHIZOPHRENIA - DISTRIBUTION AND IMPLICATIONSFOR TREATMENT, Clinical neuropharmacology, 18, 1995, pp. 110-120

Authors: KAKIGI T GAO XM TAMMINGA CA
Citation: T. Kakigi et al., DRUG-INDUCED ORAL DYSKINESIAS IN RATS AFTER TRADITIONAL AND NEW NEUROLEPTICS, Journal of neural transmission, 101(1-3), 1995, pp. 41-49

Authors: GAO XM TAMMINGA CA
Citation: Xm. Gao et Ca. Tamminga, MK801 INDUCES LATE REGIONAL INCREASES IN NMDA AND KAINATE RECEPTOR-BINDING IN RAT-BRAIN, Journal of neural transmission, 101(1-3), 1995, pp. 105-113

Authors: TAMMINGA CA HOLCOMB HH GAO XM LAHTI AC
Citation: Ca. Tamminga et al., GLUTAMATE PHARMACOLOGY AND THE TREATMENT OF SCHIZOPHRENIA - CURRENT STATUS AND FUTURE-DIRECTIONS, International clinical psychopharmacology, 10, 1995, pp. 29-37

Authors: ROSS DE THAKER GK HOLCOMB HH CASCELLA NG MEDOFF DR TAMMINGA CA
Citation: De. Ross et al., ABNORMAL SMOOTH-PURSUIT EYE-MOVEMENTS IN SCHIZOPHRENIC-PATIENTS ARE ASSOCIATED WITH CEREBRAL GLUCOSE-METABOLISM IN OCULOMOTOR REGIONS, Psychiatry research, 58(1), 1995, pp. 53-67

Authors: HOLCOMB HH RITZL EK MEDOFF DR NEVITT J GORDON B TAMMINGA CA
Citation: Hh. Holcomb et al., TONE DISCRIMINATION PERFORMANCE IN SCHIZOPHRENIC-PATIENTS AND NORMAL VOLUNTEERS - IMPACT OF STIMULUS-PRESENTATION LEVELS AND FREQUENCY DIFFERENCES, Psychiatry research, 57(1), 1995, pp. 75-82

Authors: CARPENTER WT TAMMINGA CA
Citation: Wt. Carpenter et Ca. Tamminga, WHY NEUROLEPTIC WITHDRAWAL IN SCHIZOPHRENIA, Archives of general psychiatry, 52(3), 1995, pp. 192-193

Authors: MURPHY GM TAMMINGA CA
Citation: Gm. Murphy et Ca. Tamminga, AMYLOID PLAQUES, The American journal of psychiatry, 152(9), 1995, pp. 1258-1258

Authors: CHASE TN TAMMINGA CA
Citation: Tn. Chase et Ca. Tamminga, ALZHEIMERS DEMENTIA, The American journal of psychiatry, 152(8), 1995, pp. 1110-1110

Authors: SHENTON ME MCCARLEY RW TAMMINGA CA
Citation: Me. Shenton et al., CORTEX .9. HESCHLS GYRUS AND THE PLANUM TEMPORALE, The American journal of psychiatry, 152(7), 1995, pp. 966-966

Authors: DU F SCHWARCZ R TAMMINGA CA
Citation: F. Du et al., CORTEX .8. ENTORHINAL CORTEX IN TEMPORAL-LOBE EPILEPSY, The American journal of psychiatry, 152(6), 1995, pp. 826-826

Authors: CARPENTER WT CONLEY RR BUCHANAN RW BREIER A TAMMINGA CA
Citation: Wt. Carpenter et al., PATIENT RESPONSE AND RESOURCE-MANAGEMENT - ANOTHER VIEW OF CLOZAPINE TREATMENT OF SCHIZOPHRENIA, The American journal of psychiatry, 152(6), 1995, pp. 827-832

Authors: SLOVITER RS TAMMINGA CA
Citation: Rs. Sloviter et Ca. Tamminga, THE HIPPOCAMPUS IN EPILEPSY, The American journal of psychiatry, 152(5), 1995, pp. 659-659

Authors: HOLCOMB HH BOATMAN D TAMMINGA CA
Citation: Hh. Holcomb et al., AUDITORY CORTICAL FUNCTION, The American journal of psychiatry, 152(4), 1995, pp. 504-504

Authors: WEINBERGER DR GOLDBERG TE TAMMINGA CA
Citation: Dr. Weinberger et al., CORTEX .5. PREFRONTAL LEUKOTOMY, The American journal of psychiatry, 152(3), 1995, pp. 330-331

Authors: GRAFMAN J TAMMINGA CA
Citation: J. Grafman et Ca. Tamminga, CORTEX .4. REGIONAL CEREBRAL BLOOD-FLOW, The American journal of psychiatry, 152(2), 1995, pp. 163-163

Authors: HOLCOMB HH TAMMINGA CA
Citation: Hh. Holcomb et Ca. Tamminga, NEUROIMAGING .2. REGIONAL CEREBRAL BLOOD-FLOW WITH (H2O)-O-15, The American journal of psychiatry, 152(11), 1995, pp. 1562-1562

Authors: TAMMINGA CA
Citation: Ca. Tamminga, NEUROIMAGING .1. PET WITH [F-18]FLUORODEOXYGLUCOSE, The American journal of psychiatry, 152(10), 1995, pp. 1415-1415

Authors: SELEMON LD GOLDMANRAKIC PS TAMMINGA CA
Citation: Ld. Selemon et al., CORTEX .3. PREFRONTAL CORTEX, The American journal of psychiatry, 152(1), 1995, pp. 5-5

Authors: CASCELLA NG TARAZI FI SHIRAKAWA O TAMMINGA CA
Citation: Ng. Cascella et al., SAVOXEPINE FAILS TO SELECTIVELY INFLUENCE GLUCOSE-METABOLISM IN THE RAT LIMBIC SYSTEM, Psychopharmacology, 114(2), 1994, pp. 275-280

Authors: LAHTI RA EVANS DL FIGUR LM STRATMAN NC GILL GS TAMMINGA CA
Citation: Ra. Lahti et al., DOPAMINE D4 VS DOPAMINE D2 RECEPTOR OCCUPANCY - POSSIBLE THERAPEUTIC IMPLICATIONS, Schizophrenia research, 11(2), 1994, pp. 108-109

Authors: LAHTI AC LAPORTE DJ MOKRISKI B TAMMINGA CA
Citation: Ac. Lahti et al., COMPARISON OF THE EFFECTS OF THE NMDA ANTAGONIST KETAMINE IN HALOPERIDOL-TREATED AND DRUG-FREE SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 11(2), 1994, pp. 109-109
Risultati: << | 101-125 | 126-150 | 151-158